Table 3 Detailed distributions of PHQ9, GAD7 and BRS6 [11]
PHQ9 | [0-4] (none) | [5-9] (mild) | [10-14] (moderate) | [15-19] (moderately severe) | [20-27] (severe) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
# | % | # | % | # | % | # | % | # | % | |
Male | 85 | 25.0 | 101 | 29.7 | 72 | 21.2 | 54 | 13.1 | 28 | 8.2 |
Female | 99 | 12.0 | 258 | 31.2 | 220 | 26.6 | 166 | 20.1 | 83 | 10.0 |
Whole | 184 | 15.8 | 359 | 30.8 | 292 | 25.0 | 220 | 18.9 | 111 | 9.5 |
GAD7 | [0-5] (none) | [6-10] (mild) | [11-15] (moderate) | [16-21] (severe) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
# | % | # | % | # | % | # | % | |||
Male | 144 | 42.4 | 97 | 28.5% | 51 | 15.0 | 48 | 14.1 | ||
Female | 236 | 28.6 | 272 | 32.9% | 157 | 19.0 | 161 | 19.5 | ||
Whole | 380 | 32.6 | 369 | 31.6% | 208 | 17.8 | 209 | 17.9 | ||
BRS6 | [1, 2.99] (low resilience) | [3.00, 4.30] (normal resilience) | [4.31, 5.00] (high resilience) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
# | % | # | % | # | % | |||||
Male | 92 | 27.1 | 248 | 72.9 | 0 | 0 | ||||
Female | 215 | 26.0 | 611 | 74.0 | 0 | 0 | ||||
Whole | 307 | 26.3 | 859 | 73.7 | 0 | 0 | ||||